Antiviral T cell responses: Phalanx or multipronged attack?

Journal of Experimental Medicine

Volumn 201, Issue 12, 2005, Pages 1881-1884

  Posnett, David N ^a,c   Engelhorn, Manuel E ^b,c   Houghton, Alan N ^b,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; EPITOPE; GLYCOPROTEIN B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RNA; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN;

ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; CELLULAR IMMUNITY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EXPERIMENTAL MOUSE; GENE EXPRESSION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HERPES SIMPLEX VIRUS; HISTORY; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOBIOLOGY; INFECTION CONTROL; INFECTION RESISTANCE; INFLUENZA; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE STRAIN; NONHUMAN; OUTCOMES RESEARCH; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; PROTEIN ENGINEERING; REVIEW; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; TUMOR IMMUNOLOGY; VACCINATION; VIREMIA; VIRUS INFECTION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNITY, CELLULAR; NEOPLASMS; PHOSPHOPROTEINS; RECEPTORS, ANTIGEN, T-CELL; VIRAL MATRIX PROTEINS; VIRAL PROTEINS;

EID: 22344442455     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20050928     Document Type: Review

References (29)

1. Bunde, T., A. Kirchner, B. Hoffmeister, D. Habedank, R. Hetzer, G. Cherepnev, S. Proesch, P. Reinke, H.D. Volk, H. Lehmkuhl, and F. Kern. 2005. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201:1031-1036.
2. Sacre, K., G. Carcelain, N. Cassoux, A.-M. Fillet, D. Costagliola, D. Vittecoq, D. Salmon, Z. Amoura, C. Katlama, B. Autran, and the RESTIMOP and ALT study groups. 2005. Repertoire, diversity and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease. J. Exp. Med. 201:1999-2010.
3. Britt, W.J., and S. Boppana. 2004. Human cytomegalovirus virion proteins. Hum. Immunol. 65:395-402.
4. Moss, P., and N. Khan. 2004. CD8(+) T-cell immunity to cytomegalovirus. Hum. Immunol. 65:456-464.
5. Walter, E.A., P.D. Greenberg, M.J. Gilbert, R.J. Finch, K.S. Watanabe, E.D. Thomas, and S.R. Riddell. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038-1044.
6. Basta, S., and J.R. Bennink. 2003. A survival game of hide and seek: cytomegaloviruses and MHC class I antigen presentation pathways. Viral Immunol. 16:231-242.
7. Tabi, Z., M. Moutaftsi, and L.K. Borysiewicz. 2001. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens. J. Immunol. 166:5695-5703.
8. Lauer, G.M., E. Barnes, M. Lucas, J. Timm, K. Ouchi, A.Y. Kim, C.L. Day, G.K. Robbins, D.R. Casson, M. Reiser, G. Dusheiko, T.M. Allen, R.T. Chung, B.D. Walker, and P. Klenerman. 2004. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology. 127:924-936.
9. Day, C.L., G.M. Lauer, G.K. Robbins, B. McGovern, A.G. Wurcel, R.T. Gandhi, R.T. Chung, and B.D. Walker. 2002. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J. Virol. 76:12584-12595.
10. Pantaleo, G., J.F. Demarest, T. Schacker, M. Vaccarezza, O.J. Cohen, M. Daucher, C. Graziosi, S.S. Schnittman, T.C. Quinn, G.M. Shaw, L. Perrin, G. Tambussi, A. Lazzarin, R.P. Sekaly, H. Soudeyns, L. Corey, and A.S. Fauci. 1997. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl. Acad. Sci. USA. 94:254-258.
11. Edwards, B.H., A. Bansal, S. Sabbaj, J. Bakari, M.J. Mulligan, and P.A. Goepfert. 2002. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol. 76:2298-2305.
12. Dalod, M., M. Dupuis, J.C. Deschemin, D. Sicard, D. Salmon, J.F. Delfraissy, A. Venet, M. Sinet, and J.G. Guillet. 1999. Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J. Virol. 73:7108-7116.
13. Gorochov, G., A.U. Neumann, C. Parizot, T. Li, C. Katlama, and P. Debre. 2001. Down-regulation of CD8+ T-cell expansions in patients with human immunodeficiency virus infection receiving highly active combination therapy. Blood. 97:1787-1795.
14. Gibson, L., G. Piccinini, D. Lilleri, M.G. Revello, Z. Wang, S. Markel, D.J. Diamond, and K. Luzuriaga. 2004. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J. Immunol. 172:2256-2264.
15. Lawson, T.M., S. Man, S. Williams, A.C. Boon, M. Zambon, and L.K. Borysiewicz. 2001. Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses. Int. Immunol. 13:1373-1381.
16. Messaoudi, I., J.A. Guevara Patino, R. Dyall, J. LeMaoult, and J. Nikolich-Zugich. 2002. Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. Science. 298:1797-1800.
17. Messaoudi, I., J. Lemaoult, J.A. Guevara-Patino, B.M. Metzner, and J. Nikolich-Zugich. 2004. Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense. J. Exp. Med. 200:1347-1358.
18. Dutoit, V., V. Rubio-Godoy, P.Y. Dietrich, A.L. Quiqueres, V. Schnuriger, D. Rimoldi, D. Lienard, D. Speiser, P. Guillaume, P. Batard, J.C. Cerottini, P. Romero, and D. Valmori. 2001. Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activity. Cancer Res. 61:5850-5856.
19. Fang, L., D. Yarilin, J.R. Valiando, A. Ronco, M.E. Weksler, P. Szabo, and D.N. Posnett. 2002. Tumor antigen drives a persistent oligoclonal expansion of CD8+ T cells in aged mice. Eur. J. Immunol. 32:1650-1658.
20. Nikolich-Zugich, J., M.K. Slifka, and I. Messaoudi. 2004. The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4:123-132.
21. Egen, J.G., M.S. Kuhns, and J.P. Allison. 2002. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3:611-618.
22. Melchionda, F., T.J. Fry, M.J. Milliron, M.A. McKirdy, Y. Tagaya, and C.L. Mackall. 2005. Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8(+) memory cell pool. J. Clin. Invest. 115:1177-1187.
23. Boczkowski, D., S.K. Nair, D. Snyder, and E. Gilboa. 1996. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J. Exp. Med. 184:465-472.
24. Gilboa, E., and J. Vieweg. 2004. Cancer immunotherapy with mRNA-transfected dendritic cells. Immunol. Rev. 199:251-263.
25. Barouch, D.H., J. Powers, D.M. Truitt, M.G. Kishko, J.C. Arthur, F.W. Peyerl, M.J. Kuroda, D.A. Gorgone, M.A. Lifton, C.I. Lord, V.M. Hirsch, D.C. Montefiori, A. Carville, K.G. Mansfield, K.J. Kunstman, S.M. Wolinsky, and N.L. Letvin. 2005. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants. Nat. Immunol. 6:247-252.
26. Evans, D.T., D.H. O'Connor, P. Jing, J.L. Dzuris, J. Sidney, J. da Silva, T.M. Allen, H. Horton, J.E. Venham, R.A. Rudersdorf, T. Vogel, C.D. Pauza, R.E. Bontrop, R. DeMars, A. Sette, A.L. Hughes, and D.I. Watkins. 1999. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5:1270-1276.
27. Barouch, D.H., J. Kunstman, M.J. Kuroda, J.E. Schmitz, S. Santra, F.W. Peyerl, G.R. Krivulka, K. Beaudry, M.A. Lifton, D.A. Gorgone, D.C. Montefiori, M.G. Lewis, S.M. Wolinsky, and N.L. Letvin. 2002. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415:335-339.
28. Price, D.A., S.M. West, M.R. Betts, L.E. Ruff, J.M. Brenchley, D.R. Ambrozak, Y. Edghill-Smith, M.J. Kuroda, D. Bogdan, K. Kunstman, N.L. Letvin, G. Franchini, S.M. Wolinsky, R.A. Koup, and D.C. Douek. 2004. T cell receptor recognition motifs govern immune escape patterns in acute SIV infection. Immunity. 21:793-803.
29. Welsh, R.M., and J.M. McNally. 1999. Immune deficiency, immune silencing, and clonal exhaustion of T cell responses during viral infections. Curr. Opin. Microbiol. 2:382-387.